Geode Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-667,418
| Closed | -$580K | – | 4828 |
|
|
2023
Q2 | $580K | Buy |
667,418
+273,106
| +69% | +$195K | ﹤0.01% | 3584 |
|
|
2023
Q1 | $276K | Buy |
394,312
+8,000
| +2% | +$6.48K | ﹤0.01% | 3900 |
|
|
2022
Q4 | $316K | Buy |
386,312
+13,698
| +4% | +$13.5K | ﹤0.01% | 3867 |
|
|
2022
Q3 | $387K | Buy |
372,614
+22,203
| +6% | +$35.5K | ﹤0.01% | 3865 |
|
|
2022
Q2 | $574K | Sell |
350,411
-251,368
| -42% | -$522K | ﹤0.01% | 3691 |
|
|
2022
Q1 | $1.77M | Sell |
601,779
-81,074
| -12% | -$284K | ﹤0.01% | 3310 |
|
|
2021
Q4 | $3.26M | Buy |
682,853
+73,596
| +12% | +$475K | ﹤0.01% | 3128 |
|
|
2021
Q3 | $4.61M | Buy |
609,257
+116,236
| +24% | +$744K | ﹤0.01% | 2952 |
|
|
2021
Q2 | $3.68M | Buy |
493,021
+318,084
| +182% | +$2.45M | ﹤0.01% | 3075 |
|
|
2021
Q1 | $1.36M | Buy |
174,937
+19,078
| +12% | +$191K | ﹤0.01% | 3429 |
|
|
2020
Q4 | $1.44M | Buy |
155,859
+25,416
| +19% | +$221K | ﹤0.01% | 3241 |
|
|
2020
Q3 | $900K | Buy |
130,443
+47,827
| +58% | +$290K | ﹤0.01% | 3254 |
|
|
2020
Q2 | $541K | Buy |
82,616
+4,565
| +6% | +$16.5K | ﹤0.01% | 3350 |
|
|
2020
Q1 | $145K | Hold |
78,051
| – | – | ﹤0.01% | 3645 |
|
|
2019
Q4 | $146K | Hold |
78,051
| – | – | ﹤0.01% | 3897 |
|
|
2019
Q3 | $110K | Sell |
78,051
-648
| -0.8% | -$1.42K | ﹤0.01% | 3928 |
|
|
2019
Q2 | $221K | Sell |
78,699
-44,596
| -36% | -$178K | ﹤0.01% | 3764 |
|
|
2019
Q1 | $588K | Buy |
123,295
+6,550
| +6% | +$32.2K | ﹤0.01% | 3371 |
|
|
2018
Q4 | $494K | Buy |
116,745
+39,174
| +51% | +$303K | ﹤0.01% | 3381 |
|
|
2018
Q3 | $848K | Buy |
77,571
+2,555
| +3% | +$29.9K | ﹤0.01% | 3286 |
|
|
2018
Q2 | $1.22M | Buy |
+75,016
| New | +$1.09M | ﹤0.01% | 3096 |
|
Geode Capital Management's SURF Position: Q3 2023 in Review
Geode Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 667,418 shares — an estimated $580K sold.
Geode Capital Management first reported a position in SURF in Q2 2018 and held it in 21 quarters. The position peaked at $4.61M in Q3 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.
- Geode Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Geode Capital Management sold 667,418 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $580K.
- Geode Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 21 quarters.
- Geode Capital Management's Surface Oncology, Inc. Common Stock position peaked at $4.61M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.